multiple electrode platelet aggregometry (mea) adenosine diphosphate (adp) assay (Dynabyte GmbH)
90
Structured Review
Dynabyte GmbH
multiple electrode platelet aggregometry (mea) adenosine diphosphate (adp) assay
Multiple Electrode Platelet Aggregometry (Mea) Adenosine Diphosphate (Adp) Assay, supplied by Dynabyte GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiple+electrode+aggregometry/multiple+platelet+function+analyzer/pmc04245259-70-10-14
Average 90 stars, based on 1 article reviews
Multiple Electrode Platelet Aggregometry (Mea) Adenosine Diphosphate (Adp) Assay, supplied by Dynabyte GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiple+electrode+aggregometry/multiple+platelet+function+analyzer/pmc04245259-70-10-14
Average 90 stars, based on 1 article reviews
multiple electrode platelet aggregometry (mea) adenosine diphosphate (adp) assay - by Bioz Stars,
2026-09
90/100 stars
Images
1) Product Images from "Different Influences of Hematocrit on the Results of Two Point-Of-Care Platelet Function Tests, the VerifyNow Assay and Multiple Electrode Platelet Aggregometry"
Article Title: Different Influences of Hematocrit on the Results of Two Point-Of-Care Platelet Function Tests, the VerifyNow Assay and Multiple Electrode Platelet Aggregometry
Journal: PLoS ONE
doi: 10.1371/journal.pone.0114053
Figure Legend Snippet: A: A negative correlation was observed between the PRU value and hematocrit. B: No significant correlation was observed between the MEA ADP assay results and hematocrit. MEA ADP: multiple electrode platelet aggregometry adenosine diphosphate test; PRU: P2Y12 reaction units.
Techniques Used:
Figure Legend Snippet: Scatterplots of the VerifyNow P2Y12 (A) and MEA ADP (B) assays according to the presence of anemia. The red line denotes the median value. MEA ADP: multiple electrode platelet aggregometry adenosine diphosphate test.
Techniques Used:
Figure Legend Snippet: The overall distribution pattern of each patient was different between the non-anemic (A) and anemic (B) patient groups. MEA ADP: multiple electrode platelet aggregometry adenosine diphosphate test; PRU: P2Y12 reaction units.
Techniques Used:
Figure Legend Snippet: A: Correlation analysis between the PRU value and MEA ADP assay results. B: Correlation analysis between the HPRU value and MEA ADP assay results. HPRU: hematocrit-adjusted PRU; MEA ADP: multiple-electrode platelet aggregometry adenosine diphosphate test; PRU: P2Y12 reaction units.
Techniques Used:
Related Articles
other:Article Title: Prospective Trial on the Pharmacokinetics of Clopidogrel in Hemodialysis Patients Article Snippet: Multiple Electrode Aggregometry on a Article Title: The factor XI/XIa antibody abelacimab combined with enoxaparin inhibits filter clotting in hemodialysis circuits ex vivo Article Snippet: We used the multiple electrode aggregometry on an Article Title: The factor XI/XIa antibody abelacimab combined with enoxaparin inhibits filter clotting in hemodialysis circuits ex vivo. Article Snippet: Whole blood platelet aggregometry We used the multiple electrode aggregometry on an Coagulation:Article Title: The factor XI/XIa antibody abelacimab combined with enoxaparin inhibits filter clotting in hemodialysis circuits ex vivo. Article Snippet: .. Therefore, these patients Fig. 2 Results of the platelet aggregation measured by the Article Title: The factor XI/XIa antibody abelacimab combined with enoxaparin inhibits filter clotting in hemodialysis circuits ex vivo Article Snippet: .. Fig. 2 Results of the platelet aggregation measured by the Control:Article Title: The factor XI/XIa antibody abelacimab combined with enoxaparin inhibits filter clotting in hemodialysis circuits ex vivo. Article Snippet: .. Therefore, these patients Fig. 2 Results of the platelet aggregation measured by the Article Title: The factor XI/XIa antibody abelacimab combined with enoxaparin inhibits filter clotting in hemodialysis circuits ex vivo Article Snippet: .. Fig. 2 Results of the platelet aggregation measured by the |